Lifeline Biotechnologies Stock Probability of Future Pink Sheet Price Finishing Over 2.0E-4
| LLBO Stock | USD 0.0001 0.0003 75.00% |
Lifeline |
Lifeline Biotechnologies Target Price Odds to finish over 2.0E-4
The tendency of Lifeline Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.0002 or more in 90 days |
| 0.0001 | 90 days | 0.0002 | about 72.62 |
Based on a normal probability distribution, the odds of Lifeline Biotechnologies to move over $ 0.0002 or more in 90 days from now is about 72.62 (This Lifeline Biotechnologies probability density function shows the probability of Lifeline Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Lifeline Biotechnologies price to stay between its current price of $ 0.0001 and $ 0.0002 at the end of the 90-day period is about 16.52 .
Given the investment horizon of 90 days Lifeline Biotechnologies has a beta of -1.87. This indicates as returns on its benchmark rise, returns on holding Lifeline Biotechnologies are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Lifeline Biotechnologies is expected to outperform its benchmark. In addition to that Lifeline Biotechnologies has an alpha of 10.2877, implying that it can generate a 10.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Lifeline Biotechnologies Price Density |
| Price |
Predictive Modules for Lifeline Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lifeline Biotechnologies. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lifeline Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lifeline Biotechnologies is not an exception. The market had few large corrections towards the Lifeline Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lifeline Biotechnologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lifeline Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 10.29 | |
β | Beta against Dow Jones | -1.87 | |
σ | Overall volatility | 0.0002 | |
Ir | Information ratio | 0.16 |
Lifeline Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lifeline Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lifeline Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lifeline Biotechnologies is way too risky over 90 days horizon | |
| Lifeline Biotechnologies has some characteristics of a very speculative penny stock | |
| Lifeline Biotechnologies appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (574.27 K) with profit before overhead, payroll, taxes, and interest of 0. |
Lifeline Biotechnologies Technical Analysis
Lifeline Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Lifeline Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lifeline Biotechnologies. In general, you should focus on analyzing Lifeline Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Lifeline Biotechnologies Predictive Forecast Models
Lifeline Biotechnologies' time-series forecasting models is one of many Lifeline Biotechnologies' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lifeline Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Lifeline Biotechnologies
Checking the ongoing alerts about Lifeline Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lifeline Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lifeline Biotechnologies is way too risky over 90 days horizon | |
| Lifeline Biotechnologies has some characteristics of a very speculative penny stock | |
| Lifeline Biotechnologies appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (574.27 K) with profit before overhead, payroll, taxes, and interest of 0. |
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.